Dr Zibners is co-founder of Calla Lily Clinical Care (CLCC), a company changing the way women are treated for a range of medical conditions from infertility...
Researchers in the US are collaborating to create a new light-activated “smart” bomb to treat aggressive breast cancer. The team have combined their expertise to help...
Excessive screen time among adolescents negatively impacts multiple aspects of sleep, which in turn increases the risk of depressive symptoms — particularly among girls, new research...
Covera Health has announced the launch of Protect Her – an AI-powered solution designed to enhance early detection of critical health conditions predominantly impacting women ages...
Oncology liquid biopsy company Vortex Biotech Holdings has announced a collaborative agreement with the University of Maryland Baltimore (UMB) to advance clinical investigations of Vortex’s technology...
By Aron Solomon, Pulitzer Prize-nominated writer and chief strategy officer for Amplify For decades, Depo-Provera was marketed as a convenient, long-lasting birth control option for women...
The Diagnostic Tampon invented by gynaecological health company Daye has been chosen to be part of the NHS Innovation Accelerator (NIA). The Accelerator recognises innovations that...
Hale House is set to position the Harley Street Health District as a leading cluster for Health innovation. The £52 million investment is a clear reflection...
A new study has revealed that hormonal contraceptive initiation postpartum was associated with an instantaneous increased risk of developing depression. The study set out to investigate...
US startup and breast pump innovator Willow Innovations has acquired UK femtech company Elvie, as Elvie enters into administration, During its 12 years of operations Elvie...
